Want to join the conversation?
$BAX's sales from Hospital Products was $1.6Bil for 4Q15, up 2% on constant currency basis and down 5% on reported basis. Adjusting for impact of FX and U.S. cyclophosphamide, Hospital Products sales rose 5%. Renal Products sales totaled $984MM, representing a 1% rise on constant currency basis, and 9% fall on reported basis.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.